Focus
Drug Discovery Investors: Angels and VC Firms
The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.
Strongest in New York, San Francisco and Boston
- 4,683
- Drug Discovery investors
- 239
- Angel investors
- 4,444
- People at VC/PE firms
- 1,313
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
4,683 Drug Discovery investors
Showing 461-480
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
 Wenwen He Venture Capital at AbbVie | United States | Corporate VC | Healthcare | View profile | |
 Ed Moss Vice President, Financial Advisor at Morgan Stanley | Washington, United States | Corporate VCPrivate equity | FinTechHardware | View profile | |
 Kwamena A. Co-Founder at PAVE Investments | Sydney, Australia | Family OfficeVenture capital | AICommerce | View profile | |
 Sebastian Huayamares Healthcare Associate at RA Capital Management | New York City, United States | Private equityVenture capital | AIFinTech | View profile | |
 Pierre Paffenhoff Climate Tech Venture Capital - Investment Director at Fonds de solidarité FTQ | Montreal, Canada | Private equityVenture capital | AIClimate | View profile | |
 Hilde Deleye Investor at Agentschap Innoveren & Ondernemen | Belgium | Government-backed | AIClimate | View profile | |
 Lorine S. Strategic Advisor / Angel Investor at Morgan Stanley | United Kingdom | Corporate VCPrivate equity | FinTechHardware | View profile | |
 Willem van Holthe Investor at Innovationquarter | The Hague, Netherlands | Government-backed | AIClimate | View profile | |
 Isabella Canêo Venture Partner at Bayer | São Paulo, Brazil | Corporate VC | ClimateFood | View profile | |
 Gülsüm Önder Investor at Domino Ventures | Bochum, Germany | Venture capital | AIClimate | View profile | |
 Qiyuan Dou 澜亭资本 at Lanting Capital | Los Angeles, United States | Venture capital | HardwareHealthcare | View profile | |
 Divum Raval Investment Analyst at Morgan Stanley | United States | Corporate VCPrivate equity | FinTechHardware | View profile | |
 Hélène Poirier Investor at Deca-bfc | Dijon, France | AcceleratorGovernment-backed | ClimateFood | View profile | |
 Benedicte Magerand Investor at Deca-bfc | Dijon, France | AcceleratorGovernment-backed | ClimateFood | View profile | |
 Ryota Hasegawa Venture capitalist at SBI Investment | Tokyo, Japan | Private equityVenture capital | AIHardware | View profile | |
 Angela Lam Investor at OMERS | Toronto, Canada | Government-backed | AIClimate | View profile | |
 Pierre Balard Investor at Wellcome Trust | London, United Kingdom | Government-backed | AIHealthcare | View profile | |
 Chi Wai Lee Morningside Technology Advisory LLC at Morningside | New York, United States | Private equityVenture capital | AIFinTech | View profile | |
 Adam Luo Investor at Wuxi Biologics | Alexandria, United States | Corporate VC | Healthcare | View profile | |
 Johann Krämer Founder in residence at Entrepreneurs First | London, United Kingdom | AcceleratorVenture capital | AIHardware | View profile |
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal